2201034

Source:http://linkedlifedata.com/resource/pubmed/id/2201034

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0002199, umls-concept:C0007134, umls-concept:C0021756, umls-concept:C0087111
pubmed:dateCreated	1990-9-20
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7605701
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Immunologic Factors, http://linkedlifedata.com/resource/pubmed/chemical/Interferon Type I, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
pubmed:status	MEDLINE
pubmed:issn	0361-7742
pubmed:author	pubmed-author:BrundaMM, pubmed-author:EmmonsR PRP, pubmed-author:EvansLL, pubmed-author:HoldenerE EEE, pubmed-author:LevittDD
pubmed:issnType	Print
pubmed:volume	348
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	61-9
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:2201034-Animals, pubmed-meshheading:2201034-Carcinoma, Renal Cell, pubmed-meshheading:2201034-Combined Modality Therapy, pubmed-meshheading:2201034-Drug Screening Assays, Antitumor, pubmed-meshheading:2201034-Drug Synergism, pubmed-meshheading:2201034-Humans, pubmed-meshheading:2201034-Immunologic Factors, pubmed-meshheading:2201034-Interferon Type I, pubmed-meshheading:2201034-Interleukin-2, pubmed-meshheading:2201034-Kidney Neoplasms, pubmed-meshheading:2201034-Mice, pubmed-meshheading:2201034-Randomized Controlled Trials as Topic, pubmed-meshheading:2201034-Recombinant Proteins
pubmed:year	1990
pubmed:articleTitle	Interferon-alpha and interleukin-2 in the treatment of renal cell cancer.
pubmed:affiliation	Department of Preclinical Research, F. Hoffmann-Laroche & Co., Basel, Switzerland.
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial, Review